MYO Myomo Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: MYO

Price (delayed)

$1.275

Market cap

$49.26M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.36

Enterprise value

$56.25M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 18

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the ...

Highlights
The revenue has increased by 7% year-on-year
Myomo's net income has plunged by 160% YoY but it has increased by 2.9% from the previous quarter
The EPS has shrunk by 157% YoY but it rose by 2.7% QoQ
MYO's equity has dropped by 58% year-on-year and by 21% since the previous quarter
The quick ratio has contracted by 18% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://myomo.com

Key stats

What are the main financial stats of MYO

MYO stock price

How has the Myomo stock price performed over time
Intraday
15.91%
1 week
16.97%
1 month
47.77%
1 year
-55.73%
YTD
40.11%
QTD
88.72%

Financial performance

How have Myomo's revenue and profit performed over time
Revenue
$41.21M
Gross profit
$27.18M
Operating income
-$14.04M
Net income
-$15.12M
Gross margin
66%
Net margin
-36.7%
Myomo's net income has plunged by 160% YoY but it has increased by 2.9% from the previous quarter
The company's net margin has shrunk by 145% YoY but it rose by 3.7% QoQ
The operating income has plunged by 140% YoY but it has grown by 2.5% from the previous quarter
The operating margin has plunged by 126% YoY but it has grown by 3.1% from the previous quarter

Price vs fundamentals

How does MYO's price correlate with its fundamentals

Growth

What is Myomo's growth rate over time

Valuation

What is Myomo stock price valuation
P/E
N/A
P/B
5.45
P/S
1.31
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.37
The EPS has shrunk by 157% YoY but it rose by 2.7% QoQ
MYO's equity has dropped by 58% year-on-year and by 21% since the previous quarter
The price to book (P/B) is 47% more than the last 4 quarters average of 3.2
The stock's P/S is 65% below its 5-year quarterly average of 3.2 and 6% below its last 4 quarters average of 1.2
The revenue has increased by 7% year-on-year

Efficiency

How efficient is Myomo business performance
The ROS has shrunk by 118% YoY but it rose by 10% QoQ
The return on assets has dropped by 103% year-on-year
Myomo's return on invested capital has increased by 21% QoQ and by 20% YoY
MYO's ROE is down by 20% since the previous quarter

Dividends

What is MYO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MYO.

Financial health

How did Myomo financials performed over time
Myomo's total assets is 32% higher than its total liabilities
The total liabilities has grown by 45% YoY
The quick ratio has contracted by 18% from the previous quarter
The company's debt is 111% higher than its equity
The company's debt has surged by 129% YoY but it fell by 2.2% QoQ
MYO's equity has dropped by 58% year-on-year and by 21% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.